Abstract Number: PB1459
Meeting: ISTH 2020 Congress
Background: Targeting platelet outside-in signaling inhibits thrombosis without compromising hemostasis. We previously showed that blockade of outside-in signaling was achieved by targeting the interaction of integrin β3 with c-Src. The c-Src SH3 is known to bind the canonical proline-rich motif and thereby regulates many biological processes. Therefore, it is essential to identify the sequences within SH3 responsible for the β3/SH3 interaction so that one may tell it apart from the canonical binding in the context of targeting strategy.
Aims: To identify the targets of integrin β3 in c-Src SH3 and evaluate their roles in anti-thrombosis and hemostasis in transgenic mouse model.
Methods: A synthetic small molecule known to interrupt the β3/SH3 interaction was used to mimic the β3 cytoplasmic domain. NMR, chemical shift perturbation and SPR were applied to identify the targets. Co-IP was assayed for β3/Src interaction and platelet aggregation, adhesion and spreading on immobilized fibrinogen for platelet function. The transgenic mouse model was generated and the FeCl3-induced carotid arterial thrombus formation and tail bleeding time assay were performed.
Results: The RT-loop of SH3, especially E97, was critically required for binding the small molecule and the β3 cytoplasmic domain but not necessarily for binding the canonical PXXP-containing RLP1 peptide and for the c-Src kinase activity that were primarily dependent upon the amino acids in the n-Src loop (Fig.1). The c-SrcE97A mouse model was established. The β3/Src interaction in c-SrcE97A mice was interrupted and the platelet function was significantly diminished. Notably, c-SrcE97A mice exhibited a reduced thrombotic potential in the FeCl3-induced thrombosis model with a normal hemostasis in the tail-bleeding assay (Fig.2).
Conclusions: We identified that E97 in the RT-loop of c-Src SH3 was critical for β3 binding but was unlikely to contribute significantly to the canonical binding and kinase activity. The sequences around E97 may thus serve as potential anti-thrombotic targets.
To cite this abstract in AMA style:Mao J, Wang Y, Xiao B, Long Z, Zhu K, Liu J, Ruan Z, Xi W, Luo C, Xi X. Identification of the Sequence Specificity in C-Src SH3 Required for Binding to Integrin Β3 as a Novel Anti-Thrombotic Target without Compromising Primary Hemostasis [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/identification-of-the-sequence-specificity-in-c-src-sh3-required-for-binding-to-integrin-%ce%b23-as-a-novel-anti-thrombotic-target-without-compromising-primary-hemostasis/. Accessed September 21, 2023.
« Back to ISTH 2020 Congress
ISTH Congress Abstracts - https://abstracts.isth.org/abstract/identification-of-the-sequence-specificity-in-c-src-sh3-required-for-binding-to-integrin-%ce%b23-as-a-novel-anti-thrombotic-target-without-compromising-primary-hemostasis/